CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc 's Working Capital Ratio

ORMP's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




ORMP Working Capital Ratio (May 31 2020)
III. Quarter
(Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
Y / Y Current Liabilities Change 63.27 % 113.37 % 51.5 % 16.58 % -55.42 %
Y / Y Current Assets Change 55.34 % -0.38 % 3.68 % 7.37 % 12.75 %
Working Capital Ratio MRQ 10.07 5.76 6.69 6.28 10.58
Overall Ranking # # # # #
Seq. Current Liabilities Change -19.91 % 11.49 % -13.43 % 111.22 % 4.66 %
Seq. Current Assets Change 40.06 % -4.08 % -7.75 % 25.33 % -10.18 %



Working Capital Ratio third quarter 2020 Comment
Oramed Pharmaceuticals Inc 's Current Assets grew by 40.06 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Oramed Pharmaceuticals Inc 's Working Capital Ratio to 10.07, Working Capital Ratio remained below Oramed Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest Working Capital Ratio than Oramed Pharmaceuticals Inc in third quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is ORMP most successful ?
Working Capital Ratio ORMP on the trailing twelve month basis
Working Capital Ratio third quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Overall Market # 10


Working Capital Ratio Statistics
High Average Low
67.71 14.02 3.73
(Feb 28 2014)   (Nov 30 2017)




Financial Statements
Oramed Pharmaceuticals Inc 's Current Liabilities $ 4 Millions Visit ORMP's Balance sheet
Oramed Pharmaceuticals Inc 's Current Assets $ 41 Millions Visit ORMP's Balance sheet
Source of ORMP's Sales Visit ORMP's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMay 31 2020, within Major Pharmaceutical Preparations Industry Working Capital RatioMay 31 2020 MRQ Current AssetsMay 31 2020 MRQ Current Liabilities
Allogene Therapeutics Inc   22.24 $ 909.577  Millions$ 40.895  Millions
Constellation Pharmaceuticals Inc  21.49 $ 523.099  Millions$ 24.347  Millions
Restorbio Inc   20.69 $ 73.749  Millions$ 3.564  Millions
Inspire Medical Systems inc   20.48 $ 267.108  Millions$ 13.042  Millions
Uniqure N v   17.57 $ 319.635  Millions$ 18.192  Millions
Seres Therapeutics Inc   17.47 $ 72.716  Millions$ 4.163  Millions
Glycomimetics Inc   15.81 $ 153.410  Millions$ 9.701  Millions
Apellis Pharmaceuticals inc   15.43 $ 853.825  Millions$ 55.326  Millions
Agios Pharmaceuticals Inc   14.75 $ 846.355  Millions$ 57.372  Millions
Aravive Inc   13.52 $ 61.268  Millions$ 4.532  Millions
Epizyme Inc   13.25 $ 354.664  Millions$ 26.777  Millions
Rocket Pharmaceuticals Inc   12.35 $ 255.436  Millions$ 20.685  Millions
Akcea Therapeutics Inc   12.17 $ 428.173  Millions$ 35.181  Millions
Ionis Pharmaceuticals Inc   10.94 $ 2,531.187  Millions$ 231.341  Millions
Kindred Biosciences Inc   10.47 $ 72.771  Millions$ 6.949  Millions
Corcept Therapeutics Inc  10.38 $ 438.333  Millions$ 42.243  Millions
Oramed Pharmaceuticals Inc   10.07 $ 41.303  Millions$ 4.103  Millions
United Therapeutics Corporation  9.76 $ 1,894.400  Millions$ 194.000  Millions
Sarepta Therapeutics Inc   9.26 $ 2,459.421  Millions$ 265.585  Millions
Bellerophon Therapeutics Inc   9.17 $ 60.313  Millions$ 6.577  Millions
Xencor Inc  9.08 $ 603.386  Millions$ 66.449  Millions
Aduro Biotech Inc   8.91 $ 180.980  Millions$ 20.303  Millions
Global Blood Therapeutics Inc   8.56 $ 594.033  Millions$ 69.402  Millions
Retrophin Inc   8.16 $ 505.562  Millions$ 61.933  Millions
Aimmune Therapeutics Inc   7.97 $ 323.641  Millions$ 40.602  Millions
Amarin Corp Plcuk  7.58 $ 827.611  Millions$ 109.212  Millions
Arvinas Inc   7.40 $ 249.582  Millions$ 33.720  Millions
Immunic Inc   6.91 $ 53.023  Millions$ 7.674  Millions
Flexion Therapeutics Inc   6.60 $ 246.567  Millions$ 37.357  Millions
Karyopharm Therapeutics Inc   6.51 $ 317.836  Millions$ 48.792  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TSC's Profile

Stock Price

TSC's Financials

Business Description

Fundamentals

Charts & Quotes

TSC's News

Suppliers

TSC's Competitors

Customers & Markets

Economic Indicators

TSC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071